 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
MGH Plans to Convert SNaPshot Genotyping Assay to NGS as First Step in Clinical NGS Strategy
September 19, 2012
MGH Plans to Convert SNaPshot Genotyping Assay to NGS as First Step in Clinical NGS Strategy
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Industry Observers Question Myriad's Competitive Advantage as It Looks to Launch NGS Cancer Panel
May 22, 2013 / Clinical Sequencing News - Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News - Foundation Medicine, MSKCC to Develop Sequencing-based Blood Cancer Test from DNA, RNA
May 8, 2013 / Clinical Sequencing News - Myriad Partners with RainDance for Front End of NGS-based Hereditary Cancer Panel Test
April 17, 2013 / Clinical Sequencing News - At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News